State-of-the-art cancer treatment:• Chemotherapy and radiation facilities

• On-site radiology and interventional radiology attheMedicalCenteroffice

•The largest Phase I oncology clinical trials program in the world

•State-of-the-art electronic medical records which allows for fully integrated centers

State-of-the-art radiation technology:• The CyberKnife - the only center in South Texas to offer this innovation

• Trilogy Accelerator with RAPIDARC

• Image Guided Radiation Therapy (IGRT) using On Board Imaging and Cone Beam CT

• Intensity Modulated Radiation Therapy (IMRT)

Internationally recognized cancer research program

START’s pre-clinical and research department is one of the

most advanced in the world, and was created to accelerate

the development of new anticancer drugs with the purpose

of improving quality of life and survival for patients with

cancer. START’s Phase I program has recently launched

a one-of-a-kind open-access Tumor Bank, and Phase 1

programs in Madrid, Spain and Shanghai, China.

A patient advocacy programGives patients and their representatives one person to

serve as the ambassador for the cancer center, bonding a

partnership between the cancer center and the patient.

Shelly Gunn M.D., Ph.D. Personalized MedicineUTHSCSA Medical School and Graduate School of Biomedical Sciences with a clinical pathology residency at UTHSCSA Clinical focus is the delivery of personalized cancer care to patients through genetic testing of hematological malignancies and solid tumors, with a specialty in breast cancer genome analysis. Board Certified in Clinical Pathology.

Joseph Holahan, M.D.HematologyUniversity of FloridaBoard Certified in Hematology

Steven P. Kalter, M.D.Medical OncologyBaylor College of MedicineBoard Certified in Internal Medicine, Hematology and Medical Oncology

Amy Lang, M.D.Medical OncologyUniversity of Texas Health Science Center San AntonioBoard Certified in Internal Medicine and Medical Oncology

James Mark, M.D. Gynecologic OncologyUniversity of Maryland School of Medicine, Baltimore, MarylandBoard Certified in Obstetrics and Gynecology

Alexander Miller, M.D.General Surgery & Surgical OncologyTrained in cancer surgery at MD Anderson Cancer Center, Houston, TXSpecialized in breast cancer, melanoma and skin cancer, pancreatic and gastric cancer, and sarcoma

Joaquin Mira, M.D.Radiation OncologyUniversity of Madrid SpainClinical interests include General Radiation Therapy and cancers of the lung, breast, prostate, and brain. Proficient in Gynecological and Head and Neck implants, IMRT, Radiosurgery and Brachytherapy

Steven Abbate, M.D.General Surgery & Surgical OncologyMayo Clinic Medical School and Surgical Residency at Harvard’s Massachusetts General HospitalGastrointestinal, endocrine, breast and cancer surgery with a clinical interest in cancers of the stomach and pancreas. Certified by the American Board of Surgery and a Fellow of the American College of Surgery.

Amita Patnaik, M.D., FRCPCSTART Research - Clinical InvestigatorClinical interests include malignancies of the gastrointestinal tract and anticancer drug development

Kyriakos Papadopoulos, M.D., MSc, FCP(SA)START Research - Clinical InvestigatorClinical interests include drug development and malignancies of the gastrointestinal tract and lungs

Drew W. Rasco, M.D.START Research - Clinical InvestigatorUniversity of Texas Health Science Center at San Antonio, and Internal Medicine residency at the Emory University School of Medicine in Atlanta, GA, followed with fellowships in Hematology and Oncology at the University of Texas, Southwestern Medical Center in Dallas. Board Certified in Internal Medicine

Anthony Tolcher, M.D., FRCPCSTART Research - Clinical InvestigatorUniversity of British ColumbiaSpecial interest in molecular genetic targets for cancer therapy

The mission of START is to accelerate the development of new anti-cancer drugs with the purpose of improving the quality of life and survival for patients with cancer. START consists of a team of highly trained physicians and staff, with extensive experience in Phase 1 clinical trials research.

Ardow R. Ameduri, M.D.Radiation OncologyNew York Medical CollegeSpecializes in Prostate Cancer with Brachytherapy and IMRT, and the CyberKnife

Murali Beeram, M.D., M.B.B.S.Medical OncologyOsmania Medical College, IndiaBoard Certified Medical Oncologist and Clinical Investigator

Ronald L. Drengler, M.D.Medical OncologyNational University of ParaguaySpecializes in General Medical Oncology with a special interest in clinical trials

Keith E. Eyre, M.D.Radiation OncologyTexas Tech UniversitySpecializes in CyberKnife, Gamma Knife, brain and breast cancers

Lisa Fichtel, M.D.Medical OncologyUT SouthwesternClinical interests include general Medical Oncology with special interest in brain tumors and breast cancer

Allison M. Garner, M.D., Ph.D.Medical OncologyUniversity of Texas Health Science Center at San AntonioSpecializes in General Medical Oncology

Gladys Rodriguez, M.D.Medical OncologyUniversity of Puerto Rico, School of MedicineClinical interests include cancer treatment and new drug therapy for cancer

Luis Carlos Rodriguez, M.D.Medical OncologyUniversity of Texas Health Science Center at San AntonioSpecial interest in gastrointestinal malignancies and breast cancer

Marisa Sanders, M.D.Medical OncologyUniversity of Texas Health Science Center at San AntonioGeneral Medical Oncology

Lon S. Smith, M.D.Medical OncologyLSU Medical SchoolPrincipal investigator of clinical trials involving the Pancreatic Cancer Research Team

Scott Ulmer, M.D. Medical Oncology and HematologyUniversity of Utah Huntsman Cancer InstituteBoard Certified in Hematology and Medical Oncology

Allen James White, M.D.Gynecological OncologyState University of New York in BrooklynBoard Certified in Gynecologic Oncology, Obstetrics and Gynecology

Sylvia Zubyk, M.D.Radiation OncologyUniversity of Texas Medical Branch, GalvestonBoard Certified in Radiation Oncology with special interest in breast cancer

www.TheStartCenter.com PHYSICIANS The Cure STARTs Here